Evidence map›Paper›PMID 42178236›Full record

ArticleBritish journal of haematology2026

Structural similarity between CD38 and the Duffy antigen as a potential mechanism of attenuated anti-Fy antibody reactivity with soluble CD38.

Yohei Sakai, Hideaki Matsuura, Ryusei Ito, Kakeru Ishii, Anna Yoshimine, Rie Nakagawa, Yuya Ishihara, Shota Fujiki, Shoko Arakawa, Hiroki Doi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yohei SakaiGraduate School of Health Sciences, Fujita Health University, Toyoake, Japan.ORCID https://orcid.org/0009-0000-6748-4546
Hideaki MatsuuraGraduate School of Health Sciences, Fujita Health University, Toyoake, Japan.ORCID https://orcid.org/0000-0001-6307-3379
Ryusei ItoMedical Technology Program, Fujita Health University School of Medical Sciences, Toyoake, Japan.
Kakeru IshiiMedical Technology Program, Fujita Health University School of Medical Sciences, Toyoake, Japan.
Anna YoshimineGraduate School of Health Sciences, Fujita Health University, Toyoake, Japan.
Rie NakagawaDepartment of Blood Transfusion, Fujita Health University Hospital, Toyoake, Japan.
Yuya IshiharaDepartment of Blood Transfusion, Fujita Health University Hospital, Toyoake, Japan.
Shota FujikiDepartment of Blood Transfusion, Fujita Health University Hospital, Toyoake, Japan.
Shoko ArakawaDepartment of Blood Transfusion, Fujita Health University Hospital, Toyoake, Japan.
Hiroki DoiDepartment of Cellular and Molecular Biology, Fujita Health University School of Medical Sciences, Toyoake, Japan.
Sumie FujiiDepartment of Blood Transfusion, Fujita Health University Hospital, Toyoake, Japan.ORCID https://orcid.org/0009-0006-4878-3384
Yasuo MiuraDepartment of Blood Transfusion, Fujita Health University Hospital, Toyoake, Japan.

Funding

Japan Society for the Promotion of Science JP24K18653
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

daratumumabDuffy antigenindirect anti‐globulin testpre‐transfusion testsoluble CD38

Identifiers

PMID42178236
PMCPMC13462149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.